Lung Cancer Patient given Chemotherapy through In Vivo Lung Perfusion with STEEN Solution™

STEEN Solution™ was used for the first time to give localized delivery of a chemotherapy agent to a patient suffering from metastatic lung sarcoma through In-Vivo Lung Perfusion (IVLP).  This was also the first time STEEN Solution was used to perfuse a lung on In-Vivo i.e. on a living patient. The aim of the study is to prove safety and evaluate the ability to use STEEN Solution™ to improve isolated tissue therapy.A leading hospital enrolled their first patient into a clinical trial to provide chemotherapy to patients suffering from lung sarcomas.  According to the 2016 data from the